Home › Hereditary Sensory and Autonomic Neuropathies › Florida
Hereditary Sensory and Autonomic Neuropathies clinical trials in Florida
7 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in Florida.
Study of ACR-2316 in Specific Advanced Solid Tumors
- Florida Cancer Specialist, Sarasota
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06667141Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Orlando VA Medical Center, Orlando, FL, Orlando
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Florida Cancer Specialists, Fort Myers
- Mayo Clinic (Florida), Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- and 2 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
- Research Site, Miami
- Research Site, Tampa
RecruitingPhase 1
Ages 18 to 110 · All sexes · Updated Mar 2, 2026 · NCT07064122Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Mount Sinai Comprehensive Cancer Center, Miami Beach
- Florida Cancer Specialists, North, St. Petersburg
- Florida Cancer Specialists, East, West Palm Beach
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 24, 2025 · NCT06463028From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.